D-dimer landmark trials: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 3: Line 3:
{{CMG}}
{{CMG}}


=== [[PROLONG Study]]===
{| style="font-size:120%"
=== [[PROLONG-II Study]]===
|-
=== [[The Negative Predictive Value of D-dimer on the Risk of Recurrent Venous Thromboembolism in Patients With Multiple Previous Events: a Prospective Cohort Study]]===
| [[PROLONG Study]]
=== [[VAPRED Study]]===
|-
=== [[Safety and Efficacy of a D-Dimer-Guided Strategy for Extension of Secondary Prophylaxis of Venous Thromboembolism - a Prospective and Randomized Management Trial]]===
| [[PROLONG-II Study]]
|-
| [[The Negative Predictive Value of D-dimer on the Risk of Recurrent Venous Thromboembolism in Patients With Multiple Previous Events: a Prospective Cohort Study]]
|-
| [[VAPRED Study]]
|-
| [[Safety and Efficacy of a D-Dimer-Guided Strategy for Extension of Secondary Prophylaxis of Venous Thromboembolism - a Prospective and Randomized Management Trial]]
|-
| [[PREVENT]]
|-
| [[ExACT Study]]
|}


==References==
==References==

Latest revision as of 15:33, 27 September 2013